1. $ABBV Very High Fundamental Rating -> http://www.cmlviz.com/cmld3b/lite.php?app=rc&ticker=ABBV

  2. 💊Biotech at the close DOW ▲ 293 NAS ▲ 113 S&P ▲ 35 BIB ▲ 5 IBB ▲ 12 XBI ▲ 9 $ABBV $ACAD $AGN $AKRX $ALGN $ALNY $ANAC

  3. DailyPlay for Thursday Sept 3rd, 2015 - $ABBV is in a bearish trend with negative momentum https://app.optionsplay.com/#share/55e7592a37a619071c66a6da

  4. Algo trading: OPEN signals Sep/02 BUY: $ORAN $CAKE $ALL $MO $CCK $TMO $DEI $ABBV $CSCO $DRH $CTSH $TJX $NLSN $FISV $ALU $TEVA $JNPR $EXPE

  5. $ABBV notice the 5000 sweep of SEP 60 call $2.20,last week there was a 12,000 call sweep,sometin cookin

  6. AbbVie, Bristol-Myers Squibb Look Set To Drive Cancer Market http://www.bidnessetc.com/51719-abbvie-inc-bristolmyers-squibb-co-look-set-to-drive-cancer-market/?utm_content=bufferb281b&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer $ABBV $BMY

  7. A few new setups posted on the blog today including $ABBV, $AMBA, and $WMT. Check it out here: https://www.thesupertrader.com/blog/

  8. AbbVie ($ABBV): Par Pharmaceutical begins shipping testosterone gel 1%, the generic version of AbbVie s AndroGel 1%

  9. $ABBV Analyst Rating Update

  10. Algorithmic trading: OPEN Sep/01 BUY: $TXRH $WBS $KEY $CB $XHR $HDB $TW $AMP $CMCSA $VTG $WFC $CNC $SNPS $PFE $PCRX $ABBV

  11. Sheets Smith Wealth Management Top Buys $AGN $DATA $MBLY $HZNP $SIMO $PZZA $FB $ABBV $RNST http://www.gurufocus.com/news/358009/affid/152113

  12. 💊Biotech at the close $DOW ⬇ 469 $NAS ⬇ 140 $S&P ⬇ 58 $BIB ⬇ 3 $IBB ⬇ 8 $XBI ⬇ 6 $AMGN $BIIB $CELG $GILD $REGN $ABBV

  13. Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug $ABBV http://www.fiercebiotech.com/story/bristol-myers-and-abbvie-speed-toward-fda-approval-breakthrough-cancer-drug/2015-09-01?utm_source=share&utm_medium=app&utm_campaign=Share

  14. Watching $ABBV here for a box break. Points to ponder below.

  15. @NewsForInvestors $BMY $ABBV: U.S. Food and Drug Administration Accepts for Priority Review the ... http://stockwires.com/u-s-food-and-drug-administration-accepts-for-priority-review-the

  16. 💊Biotech at the open $BIB ⬇ 2 $IBB ⬇ 5 $XBI ⬇ 3 $AMGN $BIIB $CELG $GILD $REGN $ABBV $ACAD $ACT $AGN $AKRX $ALGN

  17. $BMY $ABBV: U.S. Food and Drug Administration Accepts for Priority Review the ... http://stockwires.com/u-s-food-and-drug-administration-accepts-for-priority-review-the

  18. $BMY $ABBV: This acceptance for review marks the first in the US for a SLAMF7 ... http://stockwires.com/this-acceptance-for-review-marks-the-first-in-the-us-for-a-slamf7

  19. $ABBV is a BUY with 24.4% upside to current price of $61.00 based on averages of all analyst ratings/targets http://manyratings.com/ABBV

  20. $ABBV Get out

  21. NEWS Worthy: Amgen Poised To Dominate A $32 Billion Biosimilar Market $AMGN $ABBV

  22. 💊Biotech at the close $BIB ⬆ 5 $IBB ⬆ 11 $XBI ⬆ 6 $AMGN $BIIB $CELG $GILD $REGN $ABBV $ACAD $ACT $AGN $AKRX $ALGN

  23. RECAP 8/31 Unusual Option Activity: $ABBV Sep 67.5 C $HIMX Jan 8 C $CSCO Oct 30 C $ABBV Sep 65 C $CNX Sep 13 P $HFC Oct 50 C

  24. Four US pharma #stocks offer dividend yields at or above 3%: $JNJ $ABBV $MRK $PFE - see all of their dividend data here:...

  25. $GILD $ABBV $MRK $IBB $CELG = HC bubble but sales of Harvoni in Japan begin this Monday (TODAY). http://seekingalpha.com/article/3394005-gileads-stock-price-harvoni-pricing-and-the-threat-of-merck-a-physicians-perspective#comment-59445766